Is the paced auditory serial addition test (PASAT) a valid means of assessing executive function in Parkinson's disease?

Cortex

Volumn 43, Issue 5, 2007, Pages 601-606

  Dujardin, Kathy ^a   Denève, Caroline ^a   Ronval, Mélanie ^a   Krystkowiak, Pierre ^a   Humez, Christine ^b   Destée, Alain ^a   Defebvre, Luc ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Basal ganglia; Cognitive slowing

Indexed keywords

ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; MENTAL DETERIORATION; MENTAL FUNCTION; MENTAL PERFORMANCE; MENTAL TASK; NEUROPSYCHOLOGICAL TEST; PACED AUDITORY SERIAL ADDITION TEST; PARKINSON DISEASE; TASK PERFORMANCE; VALIDATION STUDY; WORKING MEMORY;

EID: 34447324959     PISSN: 00109452     EISSN: 00109452     Source Type: Journal    
DOI: 10.1016/S0010-9452(08)70490-8     Document Type: Article

References (23)

1. BROWN RG and MARSDEN CD. An investigation of the phenomenon of "set" in Parkinson's disease. Movement Disorders, 3: 152-161, 1988.
2. BROWN RG and MARSDEN CD. Cognitive function in Parkinson's disease: From description to theory. Trends in Neurosciences, 13: 21-29, 1990.
3. CREVITS L and DE RIDDER K. Disturbed striatoprefrontal mediated visual behavior in moderate to severe parkinsonian patients. Journal of Neurology, Neurosurgery and Psychiatry, 63: 296-299, 1997.
4. DALRYMPLE-ALFORD JC, KALDERS AS, JONES RD and WATSON RW. A central executive deficit in patients with Parkinson's disease. Journal of Neurology, Neurnsurgery and Psychiatry, 57: 360-367, 1994.
5. DEFER GL, WIDNER H, MARIÉ RM, REMY P and LEVIVIER M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders, 14: 572-584, 1999.
6. DIEHR MC, HEATON RK, MILLER W and GRANT I. The Paced Auditory Serial Addition Task (PASAT): Norms for age, education, and ethnicity. Assessment, 5: 375-387, 1998 [Effatum in Assessment, 6: 101, 1999].
7. DUJARDIN K, BLAIRY S, DEFEBVRE L, DUHEM S, NOEL Y, HESS U and DESTÉE A. Deficits in decoding emotional facial expressions in Parkinson's disease. Neuropsychologia, 42: 239-250, 2004.
8. DUJARDIN K, DEGREEF JF, REGELET P, DEFEBVRE L and DESTÉE A. Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. Journal of Neurology, 246: 783-788, 1999.
9. DUJARDIN K, KRYSTKOWIAK P, DEFEBVRE L, BLOND S and DESTéEE A. A case of severe dysexecutive syndrome consecutive to chronic bilateral pallidal stimulation. Neuropsychologia, 38: 1305-1315, 2000.
10. FAHN S, ELTON RL and MEMBERS OF THE UPDRS DEVELOPMENT COMMITTEE. Unified idiopathic Parkinson's disease rating scale. In Fahn S, Marsden CD, Calne D and Goldstein M (Eds), Recent Developments in Parkinson's Disease (vol. 2). Florham Park: Mac Millan Healthcare Information, 1987.
11. FLOWERS KA and ROBERTSON C. Perceptual abnormalities in Parkinson's disease: Top-down or bottom-up processes? Perception, 24: 1201-1221, 1995.
12. GIBB WR and LEES AJ. The prevalence of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 51: 745-752, 1988.
13. GODEFROY O, ROUSSEAUX M, LEYS D, DESTÉE A, SCHELTENS P and PRUVO JP. Frontal lobe dysfunction in unilateral lenticulostriate infarcts. Prominent role of cortical lesions. Archives of Neurology, 49: 1285-1289, 1992.
14. GRONWALL DM. Paced auditory serial addition task: A measure of recovery from concussion. Perceptual and Motor Skills, 44: 367-373, 1977.
15. LEENTJENS AF, VERHEY FR, LOUSBERG R, SPITSBERGEN H and WILMINK FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. International Journal of Geriatric Psychiatry, 15: 644-649, 2000.
16. MALAPANI C, PILLON B, DUBOIS B and AGID Y. Impaired simultaneous cognitive task performance in Parkinson's disease: A dopamine-related dysfunction. Neurology, 44: 319-326, 1994.
17. OWEN AM, JAMES M, LEIGH PN, SUMMERS BA, MARSDEN CD, QUINN NP, LANGE, KW and ROBBINS TW. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain, 115: 1727-1751, 1992.
18. OWEN AM, ROBERTS AC, HODGES JR, SUMMERS BA, POLKEY CE and ROBBINS TW. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain, 116: 1159-1175, 1993.
19. OWEN AM, SAHAKIAN BJ, HODGES JR, SUMMERS BA, POLKEY CE and ROBBINS TW. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology, 9: 126-140, 1995.
20. PILLON B, DUBOIS B and AGID Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology, 46: 324-334, 1996.
21. ROGERS D, LEES AJ, SMITH E, TRIMBLE M and STERN GM. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. Brain, 110: 761-776, 1987.
22. SAINT-CYR JA and TREPANIER LL. Neuropsychologic assessment of patients for movement disorder surgery. Movement Disorders, 15: 771-783, 2000.
23. SCHMIDT R, FRIEDL W, FAZEKAS F, REINHART B, GRIESHOPER P, KOCH M, SCHAKER M, POLMIN K and LECHNER H. The Mattis dementia rating scale: Normative data from 1001 healthy volunteers. Neurology, 44: 964-966, 1994.